Welcome

airPharma is a specialty pharmaceutical company focused on developing therapeutic products for the treatment of respiratory disease. The Company is leveraging the management team's significant expertise in respiratory product development and commercialization in specialty markets to develop a portfolio of branded respiratory products.

airPharma is focused initially on in-licensing compounds where safety and efficacy data currently exists. The Company believes this strategy will allow it to develop products rapidly with relatively low development risk. The Company intends to develop these products in niche markets where few therapies exist and a significant unmet medical need is addressed. The Company believes that by addressing niche markets where few therapies currently exist, it can achieve meaningful market penetration by leveraging a relatively small sales force targeted to specialty physician groups.